|
|
||||||||
University of Illinois at Chicago, College of Medicine, and Chicago Veterans Affairs Health Care System, West Side Division, Chicago, Illinois 60612-7315
| |
ABSTRACT |
|---|
|
|
|---|
We have previously shown that
CO2 stimulation of the renal
Na-HCO3 cotransporter (NBC)
activity is abrogated by general inhibitors of protein tyrosine
kinases. The more selective inhibitor herbimycin also blocked this
effect at concentrations known to preferentially inhibit Src family
kinases (SFKs). We therefore examined a role for SFKs in
CO2-stimulated NBC activity. To
this end, we engineered OK cells to express the COOH-terminal Src
kinase (Csk), a negative regulator of SFKs.
CO2 stimulated NBC activity
normally in
-galactosidase-expressing and untransfected control
cells. In contrast, Csk-expressing cells had normal baseline NBC
activity that was not stimulated by
CO2. CO2 stimulation increased both
total SFK activity and specific tyrosine phosphorylation of Src. The
specific MEK1/2 inhibitor PD-98059 completely inhibited
the CO2 stimulation of NBC
activity as well as the accompanying phosphorylation and activation of ERK1/2. Our data suggest the involvement of both SFKs, probably Src,
and the "classic" MAPK pathway in mediating
CO2-stimulated NBC activity in
renal epithelial cells.
Src family kinase; ERK1/2 kinase; phosphorylation
| |
INTRODUCTION |
|---|
|
|
|---|
VECTORIAL HCO3 transport from the renal proximal tubule cell into the blood is mediated by the basolateral Na-HCO3 cotransporter, NBC (2). We have shown that NBC is regulated by ambient pH (27), by glucocorticoids (23), and by activators of both G protein-coupled receptors, e.g., carbachol, angiotensin II, parathyroid hormone (21, 22, 24), and receptor protein tyrosine kinases, e.g., insulin and epidermal growth factor (EGF) (19). A number of pH-dependent and pH-independent signal transduction mechanisms, involving G proteins (25), protein kinase A (PKA), PKC, and calcium-calmodulin kinase (26), have been implicated as mediators of these effects. Of relevance to the present work, we have previously shown that general inhibitors of protein tyrosine kinases prevent the adaptive increase in NBC activity in response to acute CO2 elevation, suggesting that tyrosine phosphorylation is involved in NBC regulation (20). The nonreceptor protein tyrosine kinase c-Src plays a role in the analogous adaptive increase in renal brush border Na/H exchanger activity (NHE3) that accompanies metabolic acidosis (32). Moreover, Src kinase activity is increased by both metabolic acidosis and decreased intracellular pH (pHi) in a murine proximal tubule cell line (34). We therefore sought to examine whether Src family kinase (SFK), and Src in particular, may play a similar role in the regulation of NBC by CO2. To this end, we tested the ability of COOH-terminal Src kinase (Csk), a negative regulator of SFKs, to influence NBC activity when expressed in cultured rabbit proximal tubule cells and OK (American opossum kidney) cells. Since the "classic" MAPK pathway mediates a number of downstream effects of Src activation, we also examined its role in the stimulation of NBC by CO2.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials. Mycoplasma-free OK cells were obtained from the American Type Culture Collection (Rockville, MD) at passage 37. Mammalian expression vectors containing full-length cDNAs for rat (pLXSH/Csk) and chicken (pcDNA1/Csk) Csk were provided by Drs. Jonathan Cooper (University of Washington, Seattle, WA) and Hidesaburo Hanafusa (Rockefeller University, New York, NY), respectively. Standard DMEM-F12 cell culture medium was purchased from Atlanta Biologicals (Norcross, GA), and all other cell culture reagents, including LipofectAMINE. were obtained from GIBCO-BRL (Life Technologies, Gaithersburg, MD). The acetoxymethyl ester of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein (BCECF-AM) was purchased from Molecular Probes (Eugene, OR), amiloride was from Research Biochemicals (Natick, MA), hygromycin was from Calbiochem Novabiochem (San Diego, CA), c-Src and Csk specific antibodies were from Santa Cruz Biotechnologies (Santa Cruz, CA), and RC20 anti-phosphotyrosine was from Transduction Laboratories (Lexington, KY), ERK1/2-specific antibodies and protein tyrosine kinase assay kits specific for SFKs and ERK1/2 were obtained from Upstate Biotechnology (Lake Placid, NY). The enhanced chemiluminescent detection kit (ECL) used to analyze immunoblots was obtained from Amersham (Arlington Heights, IL). All other chemicals were purchased from Sigma Chemicals (St. Louis, MO).
Isolation and culture of rabbit proximal tubule
segments and culture of OK cells. Proximal tubules were
isolated from New Zealand White rabbits as previously described (4,
27). Electron microscopy confirmed that these preparations were
homogenous, with over 98% of the isolated tubules exhibiting
morphological characteristics of proximal tubules. We have previously
shown that explant cultures from these tubules retain morphological, enzymatic, and transport functions of the original epithelium (19-26). Isolated proximal tubules were routinely suspended and cultured in defined serum-free growth medium: a mixture (50:50) of
DMEM-F12 medium containing 24 mM
NaHCO3, 192 IU/ml penicillin, and
200 µg/ml streptomycin, 5 µg/ml bovine insulin, 5 µg/ml human transferrin, and 5 × 10
8 M hydrocortisone.
Cultures were maintained at 37°C in a 5%
CO2 incubator at pH 7.40. Growth
medium was changed regularly every 3-4 days. Confluence was
typically achieved within 8-10 days, after which cells were
detached by trypsinization and replated on clear plastic coverslips.
Confluence was typically achieved 2-3 days later, and cells were
then used for fluorometric assays of NBC activity. Cultured proximal
tubule cells were rendered quiescent by removal of hormones 48 h prior
to experimental procedures.
OK cells were cultured in standard Eagle's MEM medium supplemented with 10% fetal calf serum and were maintained in 5% CO2 at 37°C. To minimize the effects of phenotypic variation in culture, we routinely tested cells between passages 38 and 43. OK cells were typically serum deprived for 24 h prior to and during any experimental procedures.
Fluorometric assay of pHi and NBC activity in cultured renal epithelial cells. pHi was continuously monitored using the pH-sensitive fluorescent probe, BCECF as previously described (4, 23). In brief, cells grown on coverslips were perfused with a Cl-free solution to minimize contributions by both the Na-dependent Cl/HCO3 exchanger and the HCO3 /Cl exchanger. Amiloride, 1 mM, was also included to inhibit Na/H exchanger activity. The cell chamber was perfused prior to assay with a Cl-free solution containing (in mM) 25 NaHCO3, 110 sodium gluconate, 5 potassium gluconate, 9 HEPES (pH 7.40), 2 CaSO4, 1 KH2PO4, 0.5 MgSO4, 10 glucose, and 1 amiloride at a rate of 20 ml/min at 37°C. Extracellular pH was maintained constant at 7.40. Once a stable fluorescence signal was achieved, Na was removed by equimolar substitution of choline for Na. Na removal resulted in a decrease in pHi that rapidly and fully recovered upon Na readdition. NBC activity was assayed as the initial rate of pHi recovery following the addition of NaHCO3 to cells perfused in the absence of Na. pHi recovery was inhibitable by DIDS and, in the absence of chloride, was primarily attributable to NBC activity (2). pH-sensitive BCECF fluorescence was routinely calibrated in the presence of elevated extracellular K+ and the ionophore nigericin (to equilibrate intracellular and extracellular pH). All measurements were performed by dual-wavelength monitoring and ratiometric analysis (18) at pH-sensitive and pH-insensitive excitation wavelengths (F500 /F450) at the completion of each experiment. Buffer capacity of the cells was determined from the pHi change as described (18).
Lipofection-mediated gene transfer. Transfection with mammalian expression vectors encoding rat (pLXSH/Csk) or chicken (pcDNA1/Csk) Csk was accomplished by lipofection using LipofectAMINE (GIBCO-BRL) according to the manufacturer's recommendations. Rat Csk was expressed in OK cells under the control of a retroviral long terminal repeat (LTR) promoter, and stable transfectants were selected by hygromycin resistance conferred by the parent pLXSH vector (11). Individual clones were isolated and propagated in complete growth medium supplemented with 100 µg/ml hygromycin. The cells were incubated until they reached confluence before testing. Overexpression of the Csk protein was tested in 10-12 clones by Western blot analysis. Transient transfection of rabbit proximal tubule cells was achieved in a similar manner but using pcDNA1/Csk, which expresses chicken Csk under the control of a cytomegalovirus promoter (28). Cell lysate preparation and immunoblotting. Confluent cell monolayers (75 cm2) were rinsed with ice-cold phosphate-buffered saline and harvested in 1 ml of modified RIPA buffer [50 mM Tris-Cl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS] supplemented with 100 µg/ml phenylmethylsulfonyl fluoride. After incubation on ice for 30 min and centrifugation at 15,000 g for 20 min at 4°C, the resulting supernatant was mixed with SDS gel-loading buffer [50 mM Tris-Cl (pH 6.8), 100 mM dithiotreitol, 2% SDS, and 0.1% bromophenol blue], boiled for 3 min, and separated by 10% SDS-PAGE. Resolved proteins were transferred onto a nitrocellulose membrane, which was then blocked by 2.5% fraction V bovine serum albumin in TBST (20 mM Tris-Cl, pH 8.0, 150 mM NaCl, and 0.5% Tween 20) for 2 h at room temperature. Following incubation with rabbit polyclonal anti-Csk antibodies for 2 h at 4°C, specific bands corresponding to Csk were detected and quantitated by incubation with horseradish peroxidase-labeled secondary antibodies using the ECL detection kit (Amersham). Detection of specific Src and ERK1/2 phosphorylation. To examine specific phosphorylation, Src immunoprecipitates were analyzed by parallel immunoblot analyses using both rabbit polyclonal anti-Src (Santa Cruz Biotechnologies) and mouse monoclonal anti-phosphotyrosine (RC20) antibodies (Transduction Laboratories). Specific ERK1/2 phosphorylation was similarly examined in ERK1/2 immunoprecipitates using both mouse polyclonal anti-ERK1/2 (Upstate Biotechnology) and mouse monoclonal RC20 antibodies. Detection and quantitation of individual species were uniformly performed using a commercially available chemiluminescent detection system (ECL, Amersham). Measurement of SFK activity. The SFK activity was evaluated using a commercially available kinase assay kit (Upstate Biotechnology). In brief, we tested the ability of cell lysates to specifically phosphorylate a synthetic peptide substrate of SFKs corresponding to residues 6-20 of cdc2 (9). Samples were incubated in a solution containing 10 mM Tris · HCl (pH 7.2), 12.5 mM MgCl2, 10 mM MnCl2, 0.2 mM EGTA, 25 µM Na3VO4, 0.2 mM dithiothreitol, 50 µM ATP, and 10 µCi [
-32P] ATP at
30°C for 10 min before stopping the reaction by the addition of
trichloroacetic acid. An aliquot was applied to a P81 phosphocellulose
paper. Unincorporated 32P was
eluted with 7.5% phosphoric acid, and the remaining incorporated radioactivity was determined by liquid scintillation counting.
Measurement of ERK1/2 kinase activity.
Total ERK1/2 kinase activity was measured as previously described (30)
using a commercially available kit (Upstate Biotechnology). In brief,
cell lysates were tested for the ability to specifically phosphorylate
myelin basic protein in the presence of inhibitors of PKC, PKA, and
calmodulin kinase II. Samples were incubated in 100 µM ATP, 15 mM
MgCl2, containing 10 µCi
[
-32P]ATP for 10 min at 30°C before application to P81 phosphocellulose paper.
Unincorporated 32P was eluted with
7.5% phosphoric acid, and the remaining incorporated radioactivity was
determined by liquid scintillation counting.
Statistical analysis. Results are
expressed as means ± SE, and statistical comparisons were performed
by t-testing for both paired or
unpaired data where appropriate.
| |
RESULTS |
|---|
|
|
|---|
Effects of herbimycin on
CO2 stimulation of NBC
activity.
We have previously shown that 10%
CO2-stimulated NBC activity in
cultured rabbit proximal tubule cells can be blocked by general tyrosine kinase inhibitors. Pretreatment of OK cells with herbimycin at
concentrations known to preferentially inhibit SFKs,
<10
6 M (7), had no effect
on basal NBC activity, but completely blocked the increase following
exposure to 10% CO2 (Fig.
1). These findings are in agreement with
our previous observations (20) and are compatible with a postulated
role for tyrosine kinases, and SFKs in particular, in regulating NBC
activity in proximal tubule cells.
|
-galactosidase reporter gene were employed as controls. Cultured
proximal tubule cells were transiently transfected with the same
expression vector. Overexpression of Csk protein was confirmed by
Western blot analysis (Fig. 2).
|
Effect of Csk overexpression on
CO2-stimulated NBC
activity.
Figure 3A
shows the effect of 10% CO2 on
NBC activity in cultured rabbit proximal tubule cells transfected with
pLXSH/Csk or with an empty control vector. In cells transfected with
vector alone, 10% CO2 stimulated
NBC activity normally from 1.49 ± 0.07 to 2.02 ± 0.19 pH
units/min (P < 0.001). In contrast,
10% CO2 failed to stimulate NBC
activity in cells expressing Csk [Csk, 1.39 ± 0.09; Csk + 10% CO2, 1.20 ± 0.11 pH
units/min; not significant (NS)]. Baseline NBC activity was not
different between cells transfected with an empty control vector and
pLXSH/Csk. In proximal tubule cells transiently expressing the chicken
homolog of Csk, similar results were obtained. The 10%
CO2 failed to stimulate NBC (Csk, 1.49 ± 0.10 vs. Csk + 10%
CO2, 1.25 ± 0.1 pH units/min;
NS, n = 8), suggesting that the effect
is not species specific.
|
8 M dexamethasone on NBC
activity [control, 1.30 ± 0.02; dexamethasone, 1.78 ± 0.05 (P < 0.001); Csk, 1.33 ± 0.10; dexamethasone + Csk, 1.80 ± 0.06 pH units/min
(P < 0.01)]. The increase in
NBC activity by dexamethasone was of the same magnitude in both control
and Csk-expressing cells, indicating that the effect of Csk is specific for CO2.
|
Effect of CO2 on
SFK activity in OK cells.
Figure 5A shows the effect of 10%
CO2 on SFK activity.
CO2 increased SFK activity by over
50% above control levels within 3 min and then decreased toward
baseline levels at 30 min. Activation of NBC and SFK activity by
CO2 was also correlated with
increased tyrosine phosphorylation of endogenous Src, which was
similarly blocked by herbimycin, suggesting a causal relationship.
Figure 5B
shows that 10% CO2 increased
phosphorylation of Src by twofold, and herbimycin decreased
phosphorylation to control levels (expressed as percentage of control,
100%; CO2, 212.8 ± 28.8%,
P < 0.001; CO2 + herbimycin, 78.3 ± 13.4%, n = 4).
|
Effect of MEK1/2 inhibition on
CO2-stimulated NBC
activity.
Because a number of signaling pathways involving Src activation proceed
through the classic MAPK pathway (Ras
Raf1
MEK1/2
ERK1/2), we utilized the specific MEK1/2 inhibitor PD-98059 to
examine the role of this pathway. Figure 6
shows that the inhibitor failed to alter baseline activity of the
cotransporter (control, 1.58 ± 0.17; inhibitor, 1.53 ± 0.13 pH
units/min), but completely abolished the effect of 10%
CO2
(CO2, 2.17 ± 0.14;
CO2 + inhibitor, 1.57 ± 0.15 pH units/min; P < 0.02).
|
Effect of CO2 on
ERK1/2 kinase activity.
The finding that PD-98059 inhibits
CO2 stimulation of NBC activity
suggests involvement of the classic MAPK pathway. Consistent with this
interpretation, 10% CO2 increased
ERK1/2 activity by over 50% (Fig.
7A), and
this effect was also blocked by PD-98059. Tyrosine phosphorylation of
ERK1/2 correlated with activation. Figure 7,
B and
C, shows that
CO2 increased phosphorylation of ERK1/2, which was likewise blocked by PD-98059 (expressed as percentage of control, 100%; CO2, 231.6 ± 28.2%, P < 0.001;
CO2 + PD-98059, 90.1 ± 31.6%,
P < 0.001, n = 4).
|
| |
DISCUSSION |
|---|
|
|
|---|
The role of SFKs in modulating NBC and NHE3 activities has only recently been examined, but SFKs are clearly involved (10, 32, 34). This closely related family of tyrosine kinases is phylogenetically conserved and in the mouse is composed of at least nine members (Src, Yes, Fyn, Lyn, Lck, Hck, Fgn, Plk, and Yrk) (7, 12, 29). Src, Yes, and Fyn are ubiquitously expressed and have been identified in renal proximal tubule cells (3, 29). Heterologous expression of Csk (COOH-terminal Src kinase) specifically inhibits the activation of all known Src kinase family members (3, 11, 14, 17) and prevents the acidosis-induced increase in NHE3 activity in MCT medullary collecting duct cells (34). A decrease in pHi, both in the presence or absence of extracellular acidosis, increases both Src kinase activity and specific phosphorylation of endogenous 60- to 70-kDa and 120-kDa proteins in these cells (32). We have previously shown that activation of tyrosine kinases by a variety of extracellular stimuli, including insulin, EGF, and carbachol, can increase NBC activity in cultured proximal tubule cells (19). The finding that tyrosine kinase inhibitors prevent the effect of metabolic acidosis on NHE3 and CO2 on NBC activity is consistent with the hypothesis that SFKs may be involved in the regulation of both NHE3 and NBC.
OK cells are derived from proximal tubule cells and retain morphological and functional characteristics of normal proximal tubule, including regulated apical NHE3 and basolateral NBC activities. They are thus ideally suited for the simultaneous study of their regulation (8). Heterologous expression of Csk completely blocked the effects of CO2 on NBC activity in both OK cells and cultured rabbit proximal tubule cells. CO2 stimulation also increased endogenous SFK activity and phosphorylation. Taken together, these findings suggest that Src plays a role in the stimulation of NBC activity by CO2.
Activation of Src results in signaling through the classic MAPK cascade
(Ras
Raf
MEK1/2
ERK1/2) (1, 3, 5, 6, 8,
13-17, 30, 31). The "classic" MAPK pathway signaling through
ERK1/2 is activated by a variety of extracellular stimuli, including
growth factors. The upstream activator of ERK1/2, MEK1/2, is
specifically inhibited by PD-98059. It is therefore of great interest
that PD-98059-inhibitable MEK1/2 and ERK1/2 activation plays a major
role in the stimulation of NHE1 by growth factors and arginine
vasopressin (AVP) (1, 5). The finding that PD-98059 also
blocks the effect of CO2 on NBC
activity, coupled with the observation that
CO2 increases both specific ERK1/2
phosphorylation and kinase activity, strongly suggests that the classic
MAPK pathway is involved in NBC regulation. The major components of
this pathway are ubiquitously expressed along the axial nephron, and
both MEK1/2 and ERK1/2 are stimulated by EGF-1 and angiotensin II in
the kidney, with the latter acting mainly in the proximal tubule (30).
The specific mechanisms whereby ERK1/2 augments a membrane transporter activity have not been elucidated. ERK1/2 kinase activation by AVP in
platelets and by growth factors in other tissues can increase NHE1
activity independent of specific Tyr phosphorylation (5, 6). In the
brain, there is substantial evidence that angiotensin II affects
norepinephrine transporters via classic MAPK pathway activation (15,
33). Activation of ERK1/2 also results in phosphorylation of the
membrane AT1 receptor, presumably
through direct physical association with ERK1/2 (33). The above
evidence clearly suggests that ERK1/2 activation can alter membrane
transport activity by unknown mechanisms.
In conclusion, we have demonstrated that CO2 stimulation of NBC activity involves both SFK and ERK1/2 activation.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Drs. Jonathan Cooper (University of Washington, Seattle) and Hidesaburo Hanafusa (Rockefeller University, NY) for providing us with rat pLXSH/Csk and chicken pcDNA1/Csk cDNAs, respectively.
| |
FOOTNOTES |
|---|
Portions of this study were presented at the 30th Annual Meeting of the American Society of Nephrology in San Antonio, TX, on November 3, 1997.
This work was supported by funds from the Veterans Affairs Central Office Merit Review Program (to J. A. L. Arruda).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: O. S. Ruiz, Univ. of Illinois at Chicago, Section of Nephrology, M/C 793, 820 South Wood St., Chicago, IL 60612-7315 (E-mail: osruiz{at}uic.edu).
Received 28 January 1999; accepted in final form 8 June 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Aharonovitz, O.,
and
Y. Grano.
Stimulation of mitogen-activated protein kinase and Na+/H+ exchange in human platelets.
J. Biol. Chem.
271:
16494-16499,
1996
2.
Alpern, R. J.
Mechanisms oh H+/OH
/HCO
3 transport in the rat proximal convoluted tubule.
J. Gen. Physiol.
86:
613-636,
1985
3.
Arreaza, G.,
K. A. Melkonian,
M. LaFevre-Bernt,
and
D. A. Brown.
Triton X-10 resistant membrane from cultured kidney epithelial cells contain the Src family protein tyrosine kinase p62yes.
J. Biol. Chem.
269:
19123-19127,
1994
4.
Arruda, J. A. L.,
L. J. Wang,
P. Pahlavan,
and
O. S. Ruiz.
Glucocorticoids and the renal Na-H antiporter. Role in respiratory acidosis.
Regul. Pept.
48:
329-336,
1993[Medline].
5.
Bianchinit, L.,
G. L'Allemain,
and
J. Pouyssegur.
The p42/p44 mitogen-activated protein kinase cascade is determinant in mediating activation of the Na+/H+ exchanger (NHE1 isoform) in response to growth factors.
J. Biol. Chem.
272:
271-279,
1997
6.
Blenis, J.
Signal transduction via the MAP kinase: proceed at your own RSK.
Proc. Natl. Acad. Sci. USA
90:
5889-5892,
1993
7.
Bolen, J. B.,
R. B. Rowley,
C. Spana,
and
A. Y. Tsygankov.
The Src family of tyrosine protein kinases in hematopoietic signal transduction.
FASEB J.
6:
3403-3409,
1992[Abstract].
8.
Cano, A.,
P. Preisig,
and
R. Alpern.
Cyclic adenosine monophosphate acutely inhibits and chronically stimulates Na/H antiporter in OK cells.
J. Clin. Invest.
92:
1632-1638,
1993.
9.
Cheng, H. C.,
H. Nishio,
O. Hatase,
S. Rolph,
and
J. H. Wang.
A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of Src family tyrosine kinases.
J. Biol. Chem.
267:
9248-9256,
1992
10.
Chu, S. T.,
H. Tsuganezawa,
Y. Peng,
A. Cano,
M. Yanag-Isawa,
and
R. J. Alpern.
Role of tyrosine kinase pathways in ETB receptor activation of NHE-3.
Am. J. Physiol.
271 (Cell Physiol. 40):
C763-C771,
1996
11.
Cooper, J. A.,
and
B. Howell.
The when and how of Src regulation.
Cell
73:
1051-1054,
1993[Medline].
12.
De Franceschi, L.,
L. Fumagalli,
O. Olivero,
R. Corrocher,
C. A. Lowell,
and
G. Berton.
Deficiency of Src family kinases Fgr and Hck results in activation of erythrocyte K/Cl cotransport.
J. Clin. Invest.
99:
220-227,
1997[Medline].
13.
Della Rocca, G. J.,
T. V. Biesen,
Y. Daaka,
D. K. Luttrell,
L. M. Luttrell,
and
R. J. Lefkowitz.
Ras-dependent mitogen-activated protein kinase activation by G-protein-coupled receptor.
J. Biol. Chem.
272:
19125-19132,
1997
14.
Huckle, W. R.,
C. A. Prokop,
R. C. Dy,
B. Herman,
and
S. Earp.
Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner.
Mol. Cell. Biol.
10:
6290-6298,
1990
15.
Lu, D.,
H. Yang,
and
M. K. Raizada.
Angiotensin II regulation of neuromodulation: downstream signaling mechanism from activation of mitogen-activated protein kinase.
J. Cell Biol.
135:
1609-1617,
1996
16.
Malarkey, K.,
C. M. Belham,
A. Paul,
A. Graham,
A. McLees,
P. H. Scott,
and
R. Plevin.
The regulation of tyrosine kinase signaling pathways by growth factor and G-protein coupled receptors.
Biochem. J.
309:
361-375,
1995.
17.
Okada, M.,
S. Nada,
Y. Yamanashi,
T. Yamamoto,
and
H. Nakagawa.
Csk: a protein tyrosine kinase involved in regulation of Src family kinases.
J. Biol. Chem.
266:
24249-24252,
1991
18.
Roos, A.,
and
W. F. Boron.
Intracellular pH.
Physiol. Rev.
61:
296-434,
1991.
19.
Ruiz, O. S.,
Y. Y. Qiu,
L. R. Cardoso,
and
J. A. L. Arruda.
Regulation of the renal Na-HCO3 cotransporter. IX. Modulation by insulin, epidermal growth factor and carbachol.
Regul. Pept.
77:
155-161,
1998[Medline].
20.
Ruiz, O. S.,
Y. Y. Qiu,
L. J. Wang,
L. R. Cardoso,
and
J. A. L. Arruda.
Regulation of the renal Na-HCO3 cotransporter. X. Mechanism of stimulatory effect of respiratory acidosis.
J. Membr. Biol.
162:
201-208,
1998[Medline].
21.
Ruiz, O. S.,
Y. Y. Qiu,
L. R. Cardoso,
and
J. A. L. Arruda.
Regulation of renal Na-HCO3 cotransporter. VII. Mechanism of the cholinergic stimulation.
Kidney Int.
51:
1069-1077,
1997[Medline].
22.
Ruiz, O. S.,
Y. Y. Qiu,
L. J. Wang,
and
J. A. L. Arruda.
Regulation of renal Na-HCO3 cotransporter. V. Mechanism of the inhibitory effect of parathyroid hormone.
Kidney Int.
49:
396-402,
1996[Medline].
23.
Ruiz, O. S.,
L. J. Wang,
P. Pahlavan,
and
J. A. L. Arruda.
Regulation of renal Na-HCO3 cotransporter. III. Presence and modulation by glucocorticoids in primary cultures of the proximal tubule.
Kidney Int.
47:
1669-1676,
1995[Medline].
24.
Ruiz, O. S.,
Y. Y. Qiu,
L. J. Wang,
and
J. A. L. Arruda.
Regulation of renal Na-HCO3 cotransporter. IV. Mechanism of the stimulatory effect of angiotensin II.
J. Am. Soc. Nephrol.
6:
1202-1208,
1995[Abstract].
25.
Ruiz, O. S.,
Y. Y. Qiu,
L. J. Wang,
and
J. A. L. Arruda.
Regulation of renal Na-HCO3 cotransporter. II. Role of G proteins.
Am. J. Physiol.
268 (Renal Fluid Electrolyte Physiol. 37):
F461-F467,
1995
26.
Ruiz, O. S.,
and
J. A. L. Arruda.
Regulation of the renal Na-HCO3 cotransporter by cyclic AMP and calcium dependent protein kinase.
Am. J. Physiol.
262 (Renal Fluid Electrolyte Physiol. 31):
F560-F565,
1992
27.
Ruiz, O. S.,
J. A. L. Arruda,
and
Z. Talor.
Na-HCO3 cotransport and Na-H antiporter in chronic respiratory acidosis and alkalosis.
Am. J. Physiol.
256 (Renal Fluid Electrolyte Physiol. 25):
F414-F420,
1989
28.
Sabe, H.,
B. Knudsen,
M. Okada,
S. Nada,
H. Nakagawa,
and
H. Hanafusa.
Molecular cloning and expression of chicken C-terminal Src kinase: lack of stable association with c-Src protein.
Proc. Natl. Acad. Sci. USA
89:
2190-2194,
1992
29.
Sugawara, K.,
I Sugawara,
J. Bukegawa,
T. Akatsaka,
T. Yamamoto,
M. Morita,
S. Mori,
and
K. Toyoshima.
Distribution of c-yes-1 gene product in various cells and tissues.
Br. J. Cancer
63:
508-513,
1991[Medline].
30.
Terada, Y.,
T. Yamada,
M. Takayama,
H. Nonoguchi,
S. Sasaki,
K. Tomita,
and
F. Marumo.
Presence and regulation of Raf-1-K (kinase), MAPK-K, MAP-K, and S6-K in rat nephron segments.
J. Am. Soc. Nephrol.
6:
1565-1677,
1995[Abstract].
31.
Terada, Y.,
K. Tomita,
M. K. Homman,
H. Nonoguchi,
T. Yang,
T. Yamada,
K. Yuasa,
E. G. Krebs,
and
F. Marumo.
Sequential activation of MAP kinase cascade by angiotensin II in opossum kidney cells.
Kidney Int.
48:
1801-1809,
1995[Medline].
32.
Yamaji, Y.,
M. Amemiya,
A. Cano,
P. A. Preisig,
R. T. Miller,
O. W. Moe,
and
R. J. Alpern.
Overexpression of Csk inhibits acid-induced activation of NHE-3.
Proc. Natl. Acad. Sci. USA
92:
6274-6278,
1995
33.
Yang, H.,
D. Lu,
G. P. Vinson,
and
M. K. Raizada.
Involvement of MAP kinase in angiotensin II-induced phosphorylation and intracellular targeting of neuronal AT1 receptors.
J. Neurosci.
17:
1660-1669,
1997
34.
Yasuyoshi, Y.,
H. Tsuganezawa,
O. W. Moe,
and
R. J. Alpern.
Intracellular acidosis activates c-Src.
Am. J. Physiol.
272 (Cell Physiol. 41):
C886-C893,
1997
This article has been cited by other articles:
![]() |
D. M. Cohen SRC family kinases in cell volume regulation Am J Physiol Cell Physiol, March 1, 2005; 288(3): C483 - C493. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. D. Espiritu, A. A. Bernardo, R. B. Robey, and J. A. L. Arruda A central role for Pyk2-Src interaction in coupling diverse stimuli to increased epithelial NBC activity Am J Physiol Renal Physiol, October 1, 2002; 283(4): F663 - F670. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Wang, F. Li, J. H. Schwartz, P. J. Flint, and S. C. Borkan c-Src and HSP72 interact in ATP-depleted renal epithelial cells Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1667 - C1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Robey, O. S. Ruiz, J. Baniqued, D. Mahmud, D. J. D. Espiritu, A. A. Bernardo, and J. A. L. Arruda SFKs, Ras, and the classic MAPK pathway couple muscarinic receptor activation to increased Na-HCO3 cotransport activity in renal epithelial cells Am J Physiol Renal Physiol, May 1, 2001; 280(5): F844 - F850. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |